Revista Medicina Nuclear Alasbimn Journal, Year 3, Nº 14

Alasbimn Journal, Year 5, Nº 19, January 2003

Economic Utility of CEA-Scan^®; (arcitumomab) Immunoscintigraphy in the Evaluation of Patients with Colorectal Cancer.
A retrospective financial analysis based on published clinical studies.

Robert Bridwel, MD, MBA¹ and John Thropay, MD².

1 - Department of Nuclear Medicine, Walter Reed Army Medical Center, Washington, DC
2 - Beverly Oncology and Imaging Centers, Montebello, CA

Correspondencia:

	Abstract
	Introduction
	Screening for colorectal cancer
	Results of phase III trials
	Resectability defined
	Economic analysis
	European experience with CEA-Scan
	Economic feasibility of monitoring for recurrence
	Safety and tolerability
	Conclusion
	Acknowledgements
	References
	Complete version

Cita/Reference:
Bridwel, Robert, MD, MBA and Thropay, John, MD. Economic Utility of CEA-Scan^®; (arcitumomab) Immunoscintigraphy in the Evaluation of Patients with Colorectal Cancer. A retrospective financial analysis based on published clinical studies. Alasbimn Journal 5(19): january 2003. http://www.alasbimnjournal.cl/revistas/19/bridwel.html